Jaypirca Tablet, Coated
NDC Package 0002-6902-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Jaypirca (pirtobrutinib) tablets is none. This formulation utilizes a tablet, coated delivery system. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-6902 and is authorized under FDA application NDA216059.

Identification & Billing

NDC Package Code
0002-6902-30
Package Description
30 TABLET, COATED in 1 BOTTLE
Product Code
0002-6902
11-Digit Billing Format
00002690230
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Jaypirca
Non-Proprietary Name
Pirtobrutinib
Substance Name
Pirtobrutinib
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PIRTOBRUTINIB 50 mg/1
Pharmacologic Class
Usage Information
None.

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
Product Type
Human Prescription Drug
FDA Application #
NDA216059
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-27-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-6902-30 identifies a specific commercial package of 30 tablet, coated in 1 bottle of Jaypirca, a human prescription drug labeled by Eli Lilly And Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, coated is formulated for oral use and contains pirtobrutinib as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eli Lilly And Company on January 27, 2023. The current certification is valid through December 31, 2027.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002690230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-6902-30
11-Digit CMS (5-4-2)
00002-6902-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.